McBroom & Associates’s Johnson & Johnson JNJ Stock Holding History
Bought
Maintained
Sold
Other funds holding JNJ
McBroom & Associates's JNJ Position: Q3 2026 in Review
McBroom & Associates reduced its Johnson & Johnson (JNJ) stake by 11% in Q3 2026, selling an estimated $1.06M and leaving 32,884 shares worth $8.71M. The position accounts for 5.26% of the portfolio, ranked #7.
McBroom & Associates first reported a position in JNJ in Q4 2021 and has held it in 20 quarters since. The position peaked at $9.37M in Q2 2026. 2,239 funds tracked by Wall St. Rank hold JNJ as of Q3 2026.
- McBroom & Associates held 32,884 shares of Johnson & Johnson worth $8.71M as of Q3 2026.
- McBroom & Associates sold 4,002 Johnson & Johnson shares in Q3 2026, an estimated $1.06M.
- Johnson & Johnson made up 5.26% of McBroom & Associates's portfolio in Q3 2026, its #7 holding.
- McBroom & Associates first reported a position in Johnson & Johnson in Q4 2021 and has held it in 20 quarters since.
- McBroom & Associates's Johnson & Johnson position peaked at $9.37M in Q2 2026.
- 2,239 funds tracked by Wall St. Rank held Johnson & Johnson as of Q3 2026.
Based on McBroom & Associates's 13F filing for Q3 2026, filed 29 Oct 2026.